2007
DOI: 10.1016/j.mito.2007.06.003
|View full text |Cite
|
Sign up to set email alerts
|

Relationship between mitochondrial DNA mutations and clinical characteristics in human lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
27
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(27 citation statements)
references
References 37 publications
0
27
0
Order By: Relevance
“…In recent years, an increasing number of diseases have been found to be associated with mutations in the mtDNA (1)(2)(3)(4)(5)(6)(7). Furthermore, a number of different cancer types have been found to be linked to such mutations, and in many cases, these mutations result in structural modifications of enzymes of the electron-transport chain (8)(9)(10)(11). A possible factor contributing to the development of the disease is an increased production of reactive oxygen species (ROS) as a result of a specific mutation (1,9,10,12).…”
mentioning
confidence: 99%
“…In recent years, an increasing number of diseases have been found to be associated with mutations in the mtDNA (1)(2)(3)(4)(5)(6)(7). Furthermore, a number of different cancer types have been found to be linked to such mutations, and in many cases, these mutations result in structural modifications of enzymes of the electron-transport chain (8)(9)(10)(11). A possible factor contributing to the development of the disease is an increased production of reactive oxygen species (ROS) as a result of a specific mutation (1,9,10,12).…”
mentioning
confidence: 99%
“…Significantly, all of these mutations were present in the majority of the tumour cells and 90% of them were detectable in all of the mitochondrial DNA present in cells, strongly suggesting that all mitochondrial DNA molecules in the mitochondrion contain the same mutation. Breast cancer also exhibit somatic mitochondrial DNA mutations (Parrella et al, 2001;Radpour et al, 2009), in addition to kidney (Meierhofer et al, 2006) (Nagy et al, 2003), stomach (Hung et al, 2010;Jeong et al, 2010), prostate (Moro et al, 2009) (Parr et al, 2006) liver (Vivekanandan et al, 2010;Zhang et al, 2010), bladder (Dasgupta et al, 2008, head and neck (Allegra et al, 2006;Dasgupta et al, 2010;Mithani et al, 2007) and lung (Dai et al, 2006;Jin et al, 2007;Suzuki et al, 2003). Furthermore increased mitochondrial DNA mutation frequencies were associated with hereditary paraganglioma (Muller et al, 2005;Taschner et al, 2001) and thyroid cancers (Abu-Amero et al, 2005;Rogounovitch et al, 2004).…”
Section: Mitochondrial Dna Repair and Cancermentioning
confidence: 99%
“…Somatic mutations in mitochondrial DNA are increasingly linked to common diseases, including age-related degenerative disorders and cancers. Specifically, mitochondrial DNA mutations have been detected in colorectal (Habano et al, 1998;Polyak et al, 1998), breast (Parrella et al, 2001;Radpour et al, 2009) bladder (Copeland et al, 2002;Dasgupta et al, 2008;Wada et al, 2006), lung (Dai et al, 2006;Jin et al, 2007;Suzuki et al, 2003), head and neck cancers (Dasgupta et al, 2010) (Allegra et al, 2006;Mithani et al, 2007), amongst others. Furthermore, some evidence also exists suggesting that mutations in mitochondrial DNA can even accelerate disease progression (Ishikawa and Hayashi, 2010;Lee et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…These mutations have been detected with relatively higher frequency by comparison between the primary cancerous, matched para-cancerous normal, and distant normal tissues from the same patients (Brandon et al, 2006;Chatterjee et al, 2006). To date, a large number of somatic mutations have been detected among various kinds of tumor tissues, such as in breast cancer (Wang et al, 2007;Alhomidi et al, 2013), gastric cancer (Hung et al, 2010), esophageal squamous cell carcinoma (Kumimoto et al, 2004), lung cancer (Jin et al, 2007;Wang and Zhao, 2011;Fang et al, 2013;Yang Ai et al, 2013), and in aging individuals (Williams et al, 2013). Our previous study also revealed elevated somatic mutation rates through the examination of thirty entire mtDNA genomes from ten Chinese patients with lung cancer (Fang et al, 2013), as well as the poly-C repeat stretch (D310) of 79 patients (Chen et al, 2014).…”
Section: Introductionmentioning
confidence: 99%